세계의 실험실 자동화 시장 - 규모, 점유율, 동향 분석 보고서 : 프로세스별, 자동화 유형별, 최종 용도별, 지역별 부문 예측(2025-2033년)

Lab Automation Market Summary

The global lab automation market size was estimated at USD 8.27 billion in 2024 and is projected to reach USD 18.39 billion by 2033, growing at a CAGR of 9.3% from 2025 to 2033. The market growth is driven by rising demand for advanced screening, laboratory efficiency, and the adoption of advanced automated solutions globally.

Cost & Time Efficiency

Cost and time efficiency are major factors influencing the global lab automation market. Automation technologies are increasingly being used by laboratories in the biotechnology, pharmaceutical, and clinical sectors to improve productivity, reduce manual intervention, and streamline processes. Automated instruments can more accurately and quickly complete repetitive and time-consuming tasks such as pipetting, sample preparation, and data analysis than manual methods. This helps to enhance the workflow effectiveness and scientific output by freeing researchers to concentrate on higher-value tasks such as experimental design and data interpretation.

Global Lab Automation Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global lab automation market based on process, automation type, end-use, and region:

• Process Outlook (Revenue, USD Million, 2021 - 2033)
• Continuous Flow
  • By Workflow
• Sequential Processing
• Parallel Processing
  • By Components
• Consumables
• Equipment
• Discrete Processing
  • By Method
• Centrifugal Discrete Processing
• Random Access Discrete Processing
  • By Components
• Consumables
• Equipment
  • By Workflow
• Dependent Analysis
• Independent Analysis
• Automation Type Outlook (Revenue, USD Million, 2021 - 2033)
• Total Automation
  • By Steps
• Pre-analysis
  • Centrifugation
  • Sample Preparation
  • Sample Sorting
• Transport Mechanisms
• Liquid Handling
• Sample Storage
• Sample Analysis
• Modular Automation Systems
  • By Steps
• Specimen Acquisition & Identification & Labelling
• Transport Mechanisms
• Sample Preparation
• Sample Loading & Aspiration
• Reagent Handling & Storage
• Sample Analysis & Measurements
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Chemistry Analysis
• Photometry & Fluorometry
• Immunoassay Analysis
• Electrolyte Analysis
• Other
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Process
  • 1.2.2. Automation Type
  • 1.2.3. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Cost & time efficiency
    • 3.3.1.2. High-throughput screening needs
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. High costs
    • 3.3.2.2. Workforce and operational limitations
• 3.4. Business Environment Analysis
  • 3.4.1. PESTLE Analysis
  • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Process Business Analysis

• 4.1. Process Segment Dashboard
• 4.2. Global Lab Automation Market Process, Movement Analysis
• 4.3. Global Lab Automation Market Size & Trend Analysis, by Process, 2021 to 2033 (USD Million)
• 4.4. Continuous Flow
  • 4.4.1. Global continuous flow market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. By Workflow
    • 4.4.2.1. Global workflow market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.1.1. Sequential Processing
        • 4.4.2.1.1.1. Global sequential processing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.1.2. Parallel Processing
        • 4.4.2.1.2.1. Global parallel processing market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. By Components
    • 4.4.3.1. Global components market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.1.1. Consumables
        • 4.4.3.1.1.1. Global consumables market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.1.2. Equipment
        • 4.4.3.1.2.1. Global equipment market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Discrete Processing
  • 4.5.1. Global discrete processing market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. By Method
    • 4.5.2.1. Global method market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.1.1. Centrifugal Discrete Processing
        • 4.5.2.1.1.1. Global centrifugal discrete processing market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.1.2. Random Access Discrete Processing
        • 4.5.2.1.2.1. Global random access discrete processing market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. By Components
    • 4.5.3.1. Global components market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.1.1. Consumables
        • 4.5.3.1.1.1. Global consumables market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.1.2. Equipment
        • 4.5.3.1.2.1. Global equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. By Workflow
    • 4.5.4.1. Global workflow market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.4.1.1. Dependent Analysis
        • 4.5.4.1.1.1. Global dependent analysis market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.4.1.2. Independent Analysis
        • 4.5.4.1.2.1. Global independent analysis market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Automation Type Business Analysis

• 5.1. Automation Type Segment Dashboard
• 5.2. Global Lab Automation Market Automation Type, Movement Analysis
• 5.3. Global Lab Automation Market Size & Trend Analysis, by Automation Type, 2021 to 2033 (USD Million)
• 5.4. Total Automation
  • 5.4.1. Global total automation market estimates and forecasts, 2021 - 2033 (USD million)
  • 5.4.2. By Steps
    • 5.4.2.1. Global steps market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.2.1.1. Pre-analysis
        • 5.4.2.1.1.1. Global pre-analysis market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.4.2.1.1.1.1. Centrifugation
            • 5.4.2.1.1.1.1.1. Global centrifugation market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.4.2.1.1.1.2. Sample Preparation
            • 5.4.2.1.1.1.2.1. Global sample preparation market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.4.2.1.1.1.3. Sample Sorting
            • 5.4.2.1.1.1.3.1. Global sample sorting market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.2.1.2. Transport Mechanisms
        • 5.4.2.1.2.1. Global transport mechanisms market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.2.1.3. Liquid Handling
        • 5.4.2.1.3.1. Global liquid handling market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.2.1.4. Sample Storage
        • 5.4.2.1.4.1. Global sample storage market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.4.2.1.5. Sample Analysis
        • 5.4.2.1.5.1. Global sample analysis market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Modular Automation Systems
  • 5.5.1. Global modular automation systems market estimates and forecasts, 2021 - 2033 (USD million)
  • 5.5.2. By Steps
    • 5.5.2.1. Global steps market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.1. Specimen Acquisition & Identification & Labelling
        • 5.5.2.1.1.1. Global specimen acquisition & identification & labelling market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.2. Transport Mechanisms
        • 5.5.2.1.2.1. Global transport mechanisms market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.3. Sample Preparation
        • 5.5.2.1.3.1. Global sample preparation market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.4. Sample Loading & Aspiration
        • 5.5.2.1.4.1. Global sample loading & aspiration market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.5. Reagent Handling & Storage
        • 5.5.2.1.5.1. Global reagent handling & storage market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.1.6. Sample Analysis & Measurements
        • 5.5.2.1.6.1. Global sample analysis & measurements market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global Lab Automation Market End Use, Movement Analysis
• 6.3. Global Lab Automation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Clinical Chemistry Analysis
  • 6.4.1. Global clinical chemistry analysis market estimates and forecasts, 2021 - 2033 (USD million)
• 6.5. Photometry & Fluorometry
  • 6.5.1. Global photometry & fluorometry market estimates and forecasts, 2021 - 2033 (USD million)
• 6.6. Immunoassay Analysis
  • 6.6.1. Global immunoassay analysis market estimates and forecasts, 2021 - 2033 (USD million)
• 6.7. Electrolyte Analysis
  • 6.7.1. Global electrolyte analysis market estimates and forecasts, 2021 - 2033 (USD million)
• 6.8. Other
  • 6.8.1. Global other market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 7. Lab Automation Market: Regional Estimates and Trend Analysis, by Process, Automation Type, & End-Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2024 to 2033
• 7.3. North America
  • 7.3.1. North America lab automation market, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Target Disease Prevalence
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. Regulatory Framework
    • 7.3.2.5. U.S. lab automation market, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Target Disease Prevalence
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Regulatory Framework
    • 7.3.3.5. Canada lab automation market, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Target Disease Prevalence
    • 7.3.4.3. Competitive Scenario
    • 7.3.4.4. Regulatory Framework
    • 7.3.4.5. Mexico lab automation market, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe lab automation market, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Target Disease Prevalence
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Regulatory Framework
    • 7.4.2.5. UK lab automation market, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Target Disease Prevalence
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Regulatory Framework
    • 7.4.3.5. Germany lab automation market, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Target Disease Prevalence
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. Regulatory Framework
    • 7.4.4.5. France lab automation market, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Target Disease Prevalence
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Regulatory Framework
    • 7.4.5.5. Italy lab automation market, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Target Disease Prevalence
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Regulatory Framework
    • 7.4.6.5. Spain lab automation market, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Target Disease Prevalence
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Regulatory Framework
    • 7.4.7.5. Denmark lab automation market, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Target Disease Prevalence
    • 7.4.8.3. Competitive Scenario
    • 7.4.8.4. Regulatory Framework
    • 7.4.8.5. Sweden lab automation market, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Target Disease Prevalence
    • 7.4.9.3. Competitive Scenario
    • 7.4.9.4. Regulatory Framework
    • 7.4.9.5. Norway lab automation market, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific lab automation market, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Target Disease Prevalence
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Regulatory Framework
    • 7.5.2.5. Japan lab automation market, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Target Disease Prevalence
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Regulatory Framework
    • 7.5.3.5. China lab automation market, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Target Disease Prevalence
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Regulatory Framework
    • 7.5.4.5. India lab automation market, 2021 - 2033 (USD Million)
  • 7.5.5. Singapore
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Target Disease Prevalence
    • 7.5.5.3. Competitive Scenario
    • 7.5.5.4. Regulatory Framework
    • 7.5.5.5. Singapore lab automation market, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Target Disease Prevalence
    • 7.5.6.3. Competitive Scenario
    • 7.5.6.4. Regulatory Framework
    • 7.5.6.5. Australia lab automation market, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Target Disease Prevalence
    • 7.5.7.3. Competitive Scenario
    • 7.5.7.4. Regulatory Framework
    • 7.5.7.5. Thailand lab automation market, 2021 - 2033 (USD Million)
  • 7.5.8. South Korea
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Target Disease Prevalence
    • 7.5.8.3. Competitive Scenario
    • 7.5.8.4. Regulatory Framework
    • 7.5.8.5. South Korea lab automation market, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America lab automation market, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Target Disease Prevalence
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. Regulatory Framework
    • 7.6.2.5. Brazil lab automation market, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Target Disease Prevalence
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Regulatory Framework
    • 7.6.3.5. Argentina lab automation market, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA lab automation market, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Target Disease Prevalence
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. Regulatory Framework
    • 7.7.2.5. South Africa lab automation market, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Target Disease Prevalence
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. Regulatory Framework
    • 7.7.3.5. Saudi Arabia lab automation market, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Target Disease Prevalence
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Regulatory Framework
    • 7.7.4.5. UAE lab automation market, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Target Disease Prevalence
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. Regulatory Framework
    • 7.7.5.5. Kuwait lab automation market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. QIAGEN
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Process Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. PerkinElmer Inc.
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Process Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Thermo Fisher Scientific, Inc.
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Process Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Siemens Healthcare GmbH
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Process Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Danaher
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Process Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Agilent Technologies, Inc.
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Process Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Eppendorf SE
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Process Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Hudson Robotics
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Process Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Aurora Biomed Inc.
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Process Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. BMG LABTECH GmbH
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Process Benchmarking
    • 8.4.10.4. Strategic Initiatives
  • 8.4.11. F. Hoffmann-La Roche Ltd
    • 8.4.11.1. Overview
    • 8.4.11.2. Financial Performance
    • 8.4.11.3. Process Benchmarking
    • 8.4.11.4. Strategic Initiatives